These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24434619)

  • 1. In vitro phosphorylation does not influence the aggregation kinetics of WT α-synuclein in contrast to its phosphorylation mutants.
    Schreurs S; Gerard M; Derua R; Waelkens E; Taymans JM; Baekelandt V; Engelborghs Y
    Int J Mol Sci; 2014 Jan; 15(1):1040-67. PubMed ID: 24434619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conformation and the aggregation kinetics of α-synuclein depend on the proline residues in its C-terminal region.
    Meuvis J; Gerard M; Desender L; Baekelandt V; Engelborghs Y
    Biochemistry; 2010 Nov; 49(43):9345-52. PubMed ID: 20828147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson's disease-like pathology.
    Gerard M; Deleersnijder A; Daniëls V; Schreurs S; Munck S; Reumers V; Pottel H; Engelborghs Y; Van den Haute C; Taymans JM; Debyser Z; Baekelandt V
    J Neurosci; 2010 Feb; 30(7):2454-63. PubMed ID: 20164329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease.
    Gorbatyuk OS; Li S; Sullivan LF; Chen W; Kondrikova G; Manfredsson FP; Mandel RJ; Muzyczka N
    Proc Natl Acad Sci U S A; 2008 Jan; 105(2):763-8. PubMed ID: 18178617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The H50Q mutation enhances α-synuclein aggregation, secretion, and toxicity.
    Khalaf O; Fauvet B; Oueslati A; Dikiy I; Mahul-Mellier AL; Ruggeri FS; Mbefo MK; Vercruysse F; Dietler G; Lee SJ; Eliezer D; Lashuel HA
    J Biol Chem; 2014 Aug; 289(32):21856-76. PubMed ID: 24936070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
    Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
    ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of lysine 63-linked ubiquitin conjugates by phosphorylated alpha-synuclein implies Lewy body biogenesis.
    Liu C; Fei E; Jia N; Wang H; Tao R; Iwata A; Nukina N; Zhou J; Wang G
    J Biol Chem; 2007 May; 282(19):14558-66. PubMed ID: 17360705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.
    Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA
    Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage of normal and pathological forms of alpha-synuclein by neurosin in vitro.
    Kasai T; Tokuda T; Yamaguchi N; Watanabe Y; Kametani F; Nakagawa M; Mizuno T
    Neurosci Lett; 2008 May; 436(1):52-6. PubMed ID: 18358605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine-mediated oxidation of methionine 127 in α-synuclein causes cytotoxicity and oligomerization of α-synuclein.
    Nakaso K; Tajima N; Ito S; Teraoka M; Yamashita A; Horikoshi Y; Kikuchi D; Mochida S; Nakashima K; Matsura T
    PLoS One; 2013; 8(2):e55068. PubMed ID: 23457458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.
    Sato H; Arawaka S; Hara S; Fukushima S; Koga K; Koyama S; Kato T
    J Neurosci; 2011 Nov; 31(46):16884-94. PubMed ID: 22090514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Oxo-2-Nonenal- and Agitation-Induced Aggregates of α-Synuclein and Phosphorylated α-Synuclein with Distinct Biophysical Properties and Biomedical Applications.
    Wang T; Liu W; Zhang Q; Jiao J; Wang Z; Gao G; Yang H
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ser-129 phosphorylation on interaction of α-synuclein with synaptic and cellular membranes.
    Visanji NP; Wislet-Gendebien S; Oschipok LW; Zhang G; Aubert I; Fraser PE; Tandon A
    J Biol Chem; 2011 Oct; 286(41):35863-35873. PubMed ID: 21849493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation.
    Elsholz L; Wasser Y; Ziegler P; Habib P; Voigt A
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease.
    Febbraro F; Sahin G; Farran A; Soares S; Jensen PH; Kirik D; Romero-Ramos M
    Neurobiol Dis; 2013 Aug; 56():47-58. PubMed ID: 23567651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
    Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
    J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.
    McFarland NR; Fan Z; Xu K; Schwarzschild MA; Feany MB; Hyman BT; McLean PJ
    J Neuropathol Exp Neurol; 2009 May; 68(5):515-24. PubMed ID: 19525899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.